Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$44.36 USD
-0.18 (-0.40%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $44.38 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Top 15% (38 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.82 | 9.99 |
Current Quarter Estimate | 1.03 | 1.57 | 61.00 |
Year Ago Quarter Estimate | 1.15 | -0.94 | 54.84 |
Next Quarter Estimate | 1.01 | 1.79 | 63.00 |
Next Year Estimate | 4.50 | 6.82 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 21.08 | 21.60 | 15.67 |
Next Year | 11.94 | 7.20 | 11.34 |
Last 5 Years | 55.00 | 0.10 | 8.10 |
Next 5 Years | 14.20 | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 11.11 | 3.25 |
Price/Book (MRQ) | 3.05 | 1.95 |
Price/Cash Flow (MRFY) | 10.20 | 10.51 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 23.36% | -70.47% |
Return on Equity (TTM) | 29.79% | -48.41% |
Debt to Equity (MRQ) | 0.82 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.